Scalable HPC & AI Infrastructure for COVID-19 Therapeutics

被引：3

作者：

Lee, Hyungro ^{[1
]}

Merzky, Andre ^{[1
]}

Tan, Li ^{[2
]}

Titov, Mikhail ^{[1
]}

Turilli, Matteo ^{[1
]}

Alfe, Dario ^{[3
]}

Bhati, Agastya ^{[3
]}

Brace, Alex ^{[4
]}

Clyde, Austin ^{[5
]}

Coveney, Peter ^{[3
]}

Ma, Heng ^{[4
]}

Ramanathan, Arvind ^{[4
]}

Stevens, Rick ^{[5
]}

Trifan, Anda ^{[6
]}

Van Dam, Hubertus ^{[2
]}

Wan, Shunzhou ^{[3
]}

Wilkinson, Sean ^{[7
]}

Jha, Shantenu ^{[1
,2
]}

机构：

[1] Rutgers State Univ, Piscataway, NJ 08854 USA

[2] Brookhaven Natl Lab, Upton, NY 11973 USA

[3] UCL, London, England

[4] Argonne Natl Lab, Lemont, IL USA

[5] Univ Chicago, Chicago, IL 60637 USA

[6] Univ Illinois, Champaign, IL USA

[7] Oak Ridge Natl Lab, Knoxville, TN USA

来源：

PROCEEDINGS OF THE PLATFORM FOR ADVANCED SCIENTIFIC COMPUTING CONFERENCE (PASC '21) | 2021年

基金：

美国能源部; 欧盟地平线“2020”;

关键词：

high-performance computing; machine learning; workflows; docking molecular dynamics; free energy estimation; COVID-19; FREE-ENERGY; PREDICTION;

D O I：

10.1145/3468267.3470573

中图分类号：

TP39 [计算机的应用];

学科分类号：

081203 ; 0835 ;

摘要：

COVID-19 has claimed more than 2.7 x 10(6) lives and resulted in over 124 x 10(6) infections. There is an urgent need to identify drugs that can inhibit SARS-CoV-2. We discuss innovations in computational infrastructure and methods that are accelerating and advancing drug design. Specifically, we describe several methods that integrate artificial intelligence and simulation-based approaches, and the design of computational infrastructure to support these methods at scale. We discuss their implementation, characterize their performance, and highlight science advances that these capabilities have enabled.

引用

页数：13

共 50 条

[1] Overview of HPC and AI Computing for COVID-19 in the US
Stevens, Rick L.
PACT '20: PROCEEDINGS OF THE ACM INTERNATIONAL CONFERENCE ON PARALLEL ARCHITECTURES AND COMPILATION TECHNIQUES, 2020, : 1 - 1
[2] Fighting COVID-19 with HPC
不详
NATURE COMPUTATIONAL SCIENCE, 2021, 1 (12): : 769 - 770
[3] Fighting COVID-19 with HPC
Nature Computational Science, 2021, 1 : 769 - 770
[4] Therapeutics for COVID-19
Toussi, Sima S.
Hammond, Jennifer L.
Gerstenberger, Brian S.
Anderson, Annaliesa S.
NATURE MICROBIOLOGY, 2023, 8 (05) : 771 - 786
[5] COVID-19 therapeutics
Focosi, Daniele
Franchini, Massimo
Maggi, Fabrizio
Shoham, Shmuel
CLINICAL MICROBIOLOGY REVIEWS, 2024, 37 (02) : e0011923
[6] Therapeutics for COVID-19
Sima S. Toussi
Jennifer L. Hammond
Brian S. Gerstenberger
Annaliesa S. Anderson
Nature Microbiology, 2023, 8 : 771 - 786
[7] The Convergence of HPC, AI and Big Data in Rapid-Response to the COVID-19 Pandemic
Sukumar, Sreenivas R.
Balma, Jacob A.
Rickett, Christopher D.
Maschhoff, Kristyn J.
Landman, Joseph
Yates, Charles R.
Chittiboyina, Amar G.
Peterson, Yuri K.
Vose, Aaron
Byler, Kendall
Baudry, Jerome
Khan, Ikhlas A.
DRIVING SCIENTIFIC AND ENGINEERING DISCOVERIES THROUGH THE INTEGRATION OF EXPERIMENT, BIG DATA, AND MODELING AND SIMULATION, 2022, 1512 : 157 - 172
[8] COVID-19 and AI
Narayan, Mahesh
CHEMICAL & ENGINEERING NEWS, 2021, 99 (37) : 3 - 3
[9] AI & COVID-19
Bacciu, Davide
Girardi, Emanuela
Maratea, Marco
Sousa, Jose
INTELLIGENZA ARTIFICIALE, 2021, 15 (02) : 45 - 53
[10] COVID-19: Vaccines and therapeutics
Ponnampalli, Swapna
Birudukota, Naga Venkata Suryanarayana
Kamal, Ahmed
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2022, 75

← 1 2 3 4 5 →